Caricamento...
Non–Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice Experiment
Background. There has been much innovation in the treatment of non–small cell lung cancer (NSCLC) in recent years. In particular, use of immuno-oncology (IO) therapies has been growing. Methods. Patients with NSCLC in the United States were surveyed online using a discrete choice experiment to elici...
Salvato in:
| Pubblicato in: | MDM Policy Pract |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7249575/ https://ncbi.nlm.nih.gov/pubmed/32548305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2381468320922208 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|